Diagnamed Holdings Corp.
CNQ: DMED.CN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Canadian Securities Exchange
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- John Karagiannidis
- Headquarters
- Toronto, Canada
- IPO year
- 2022
- Market cap
- CA$6.0M
- Website
- https://www.diagnamed.com
Loading DMED…
Loading profile data…Frequently asked questions about DMED
What does Diagnamed Holdings Corp. (DMED.CN) do?
Diagnamed Holdings Corp. engages in developing a platform of software-based prescription digital therapeutic products for detecting brain age and tremors for neurological disorders. The company is headquartered in Vancouver, Canada.
Where does DMED.CN trade?
Diagnamed Holdings Corp. (DMED.CN) trades on the Canadian Securities Exchange.
What sector is DMED.CN in?
Diagnamed Holdings Corp. (DMED.CN) operates in the Healthcare sector, specifically in the Medical - Healthcare Information Services industry.
Who is the CEO of Diagnamed Holdings Corp.?
John Karagiannidis is the chief executive officer of Diagnamed Holdings Corp. (DMED.CN).
Where is Diagnamed Holdings Corp. headquartered?
Diagnamed Holdings Corp. is headquartered in Canada.
Does DMED.CN pay a dividend?
Diagnamed Holdings Corp. (DMED.CN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did DMED.CN go public?
Diagnamed Holdings Corp. (DMED.CN) completed its initial public offering in 2022.